Pathological angiogenesis: mechanisms and therapeutic strategies

AC Dudley, AW Griffioen - Angiogenesis, 2023 - Springer
In multicellular organisms, angiogenesis, the formation of new blood vessels from pre-
existing ones, is an essential process for growth and development. Different mechanisms …

Cell type-specific roles of NF-κB linking inflammation and thrombosis

M Mussbacher, M Salzmann, C Brostjan… - Frontiers in …, 2019 - frontiersin.org
The transcription factor NF-κB is a central mediator of inflammation with multiple links to
thrombotic processes. In this review, we focus on the role of NF-κB signaling in cell types …

Endothelial to mesenchymal transition: role in physiology and in the pathogenesis of human diseases

S Piera-Velazquez, SA Jimenez - Physiological reviews, 2019 - journals.physiology.org
Numerous studies have demonstrated that endothelial cells are capable of undergoing
endothelial to mesenchymal transition (EndMT), a newly recognized type of cellular …

Endothelial-mesenchymal transition in cardiovascular disease

Z Alvandi, J Bischoff - Arteriosclerosis, thrombosis, and vascular …, 2021 - Am Heart Assoc
Endothelial-to-mesenchymal transition is a dynamic process in which endothelial cells
suppress constituent endothelial properties and take on mesenchymal cell behaviors. To …

Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF‐β/Smad signalling in type 2 diabetic rats

J Tian, M Zhang, M Suo, D Liu, X Wang… - Journal of cellular …, 2021 - Wiley Online Library
Diabetic cardiomyopathy (DCM) is one of the leading causes of heart failure in patients with
diabetes mellitus, with limited effective treatments. The cardioprotective effects of sodium …

TGF-β-induced endothelial-mesenchymal transition in fibrotic diseases

E Pardali, G Sanchez-Duffhues… - International journal of …, 2017 - mdpi.com
Fibrotic diseases are characterized by net accumulation of extracellular matrix proteins in
affected organs leading to their dysfunction and ultimate failure. Myofibroblasts have been …

Reassessing endothelial-to-mesenchymal transition in cardiovascular diseases

Y Li, KO Lui, B Zhou - Nature Reviews Cardiology, 2018 - nature.com
Endothelial cells and mesenchymal cells are two different cell types with distinct
morphologies, phenotypes, functions, and gene profiles. Accumulating evidence, notably …

Emerging roles of inflammation-mediated endothelial–mesenchymal transition in health and disease

Y Yoshimatsu, T Watabe - Inflammation and Regeneration, 2022 - Springer
Abstract Endothelial–mesenchymal transition (EndoMT), a cellular differentiation process in
which endothelial cells (ECs) lose their properties and differentiate into mesenchymal cells …

TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation

Y Yoshimatsu, I Wakabayashi, S Kimuro… - Cancer …, 2020 - Wiley Online Library
The tumor microenvironment (TME) consists of various components including cancer cells,
tumor vessels, cancer‐associated fibroblasts (CAFs), and inflammatory cells. These …

[HTML][HTML] SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition

ZH Liu, Y Zhang, X Wang, XF Fan, Y Zhang, X Li… - Biomedicine & …, 2019 - Elsevier
Endothelial-to-mesenchymal transition (EndMT) is closely related to the pathogenesis of
various diseases, including cardiac fibrosis. Transforming growth factor (TGF)-β1 strongly …